Diversion Control Homepage Diversion Control Homepage Privacy Policy Contact Us What's New Hot Items Site Map Search Diversion SiteDEA Diversion Control Program Logo and Banner

 

Federal Register Notices > Notice of Registration 2006 > Organichem Corporation

Notice of Registration - 2006 


FR Doc E6-11690 [Federal Register: July 24, 2006 (Volume 71, Number 141)] [Notices] [Page 41841] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr24jy06-117]

[[Page 41841]]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated March 20, 2006, and published in the Federal Register on March 27, 2006, (71 FR 15219), Organichem Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules I and II:

Drug Schedule 
Marihuana (7360)   I
Tetrahydrocannabinols (7370)   I
Amphetamine (1100)   II
Methylphenidate (1724)   II
Pentobarbital (2270)   II
Hydrocodone (9193)   II
Meperidine (9230)   II
Dextropropoxyphene (9273)   II
Fentanyl (9801)   II

The company plans to manufacture bulk controlled substances for use in product development and for distribution to its customers. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabindiol as a synthetic intermediate. This controlled substance will be further synthesized to bulk manufacture a synthetic THC (7370). No other activity for this drug code is authorized for this registration.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Organichem Corporation to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Organichem Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: July 10, 2006.

Joseph T. Rannazzisi, 
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. E6-11690 Filed 7-21-06; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of these publications may be obtained directly from the Government Printing Office (GPO).


     HOME

CONTACT US

SEARCH

BACK TO TOP